Tacrolimus therapy for refractory acute renal allograft rejection: a 4-year experience with an aggressive approach

Transplant Proc. 1998 Jun;30(4):1234-5. doi: 10.1016/s0041-1345(98)00223-1.
No abstract available

Publication types

  • Clinical Trial

MeSH terms

  • Acute Disease
  • Adolescent
  • Adult
  • Aged
  • Azathioprine / therapeutic use
  • Biopsy, Needle
  • Cyclosporine / therapeutic use
  • Female
  • Follow-Up Studies
  • Graft Rejection / drug therapy*
  • Graft Rejection / mortality
  • Graft Rejection / pathology
  • Graft Survival
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Kidney Transplantation / immunology*
  • Kidney Transplantation / mortality
  • Kidney Transplantation / pathology
  • Male
  • Middle Aged
  • Muromonab-CD3 / therapeutic use
  • Survival Rate
  • Tacrolimus / therapeutic use*

Substances

  • Immunosuppressive Agents
  • Muromonab-CD3
  • Cyclosporine
  • Azathioprine
  • Tacrolimus